KIRSTEN SHORT: Open Payments
NPI 1932598968 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,953 in 104 payments from 14 companies in 2025. Trend: 2023 $1,301 · 2024 $1,733 · 2025 $1,953
Food & beverage: $1,882Education: $71
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 26 | $476 |
| Regeneron Healthcare Solutions, Inc. | 12 | $372 |
| Janssen Biotech, Inc. | 9 | $254 |
| Galderma Laboratories, L.P. | 18 | $195 |
| E.R. Squibb & Sons, L.L.C. | 11 | $154 |
| ABBVIE INC. | 15 | $135 |
| Regeneron Pharmaceuticals, Inc. | 1 | $105 |
| Lilly USA, LLC | 2 | $77 |
| GENZYME CORPORATION | 3 | $67 |
| LEO Pharma Inc. | 2 | $48 |
Products named: DUPIXENT, CIBINQO, TREMFYA, NEMLUVIO, Sotyktu, SKYRIZI, RINVOQ, EBGLYSS.
Industry payments across OK — which companies pay providers there.
